Stock Events

Stock Events

Sarepta Therapeutics 

$19.00
286
+$0.38+2.04%Thursday 08:10

Statistics

Day High
19.08
Day Low
19
52W High
22.16
52W Low
14.9
Volume
29
Avg. Volume
-
Mkt Cap
2.01B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q3 2025
Q1 2026
Q2 2026
Next
-1.8
-0.24
1.32
2.88
Expected EPS
0.074027
Actual EPS
N/A

Financials

-32.45%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.2BRevenue
-713.41MNet Income

Analyst Ratings

$18.00Average Price Target
The highest estimate is ⁦27.00⁩.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
17%
Hold
50%
Sell
33%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SRPT.BOATS. It's not an investment recommendation.
NVIDIA
42
NVDA
AMD
36
AMD
Amazon
35
AMZN
Microsoft
34
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is developing gene therapies for Duchenne muscular dystrophy (DMD), directly competing with Sarepta's DMD treatments.
Sorrento Therapeutics
SRNE
Mkt Cap385,896
Sorrento Therapeutics has a diverse pipeline including treatments for diseases that Sarepta also targets, making them competitors in the biotech space.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.33B
BioMarin Pharmaceutical competes with Sarepta in the rare disease space, particularly in treatments for DMD.
PTC Therapeutics
PTCT
Mkt Cap5.01B
PTC Therapeutics offers treatment for DMD, competing directly with Sarepta's DMD therapies.
Solid Biosciences
SLDB
Mkt Cap664.8M
Solid Biosciences is focused on developing therapies for DMD, positioning it as a direct competitor to Sarepta.
Dyadic International DE
DYAI
Mkt Cap15.23M
Dyadic International is working on developing and manufacturing biopharmaceuticals for diseases that Sarepta also targets.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals is involved in treating cystic fibrosis and other diseases, competing with Sarepta in the broader rare disease market.
Ultragenyx Pharmaceutical
RARE
Mkt Cap1.59B
Ultragenyx Pharmaceutical focuses on rare diseases, including some that overlap with Sarepta's target indications.
Biogen
BIIB
Mkt Cap37.49B
Biogen has a broad portfolio in neurology and rare diseases, competing with Sarepta in areas like gene therapy for neurological disorders.

About

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
Show More
CEO
ISIN
US8036071004

Listings

MX
MX
SRPT.MX
MI
IT
1SRPT.MI
SA
BR
S1RP34.SA
LSE
GB
0L35.LSE

0 Comments

Share your thoughts

FAQs

What is Sarepta Therapeutics stock price today?▼
The current price of SRPT.BOATS is $19.00 USD — it has increased by +2.04% in the past 24 hours. Watch Sarepta Therapeutics stock price performance more closely on the chart.
What is Sarepta Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Sarepta Therapeutics stocks are traded under the ticker SRPT.BOATS.
What is Sarepta Therapeutics market cap?▼
Today Sarepta Therapeutics has the market capitalization of 2.01B
When is the next Sarepta Therapeutics earnings date?▼
Sarepta Therapeutics is going to release the next earnings report on March 3, 2027.
What is Sarepta Therapeutics revenue for the last year?▼
Sarepta Therapeutics revenue for the last year amounts to 2.2B USD.
What is Sarepta Therapeutics net income for the last year?▼
SRPT.BOATS net income for the last year is -713.41M USD.
In which sector is Sarepta Therapeutics located?▼
Sarepta Therapeutics operates in the Other sector.
When did Sarepta Therapeutics complete a stock split?▼
Sarepta Therapeutics has not had any recent stock splits.